Photoactivation at a clinical LINAC: The 197Au(gamma,n)196Au reaction
  slightly above threshold by Mohr, P. et al.
ar
X
iv
:0
70
7.
29
33
v1
  [
nu
cl-
ex
]  
19
 Ju
l 2
00
7
Photoactivation at a clinical LINAC: The
197Au(γ,n)196Au reaction slightly above
threshold
P. Mohr a S. Brieger a G. Witucki a M. Maetz b
aStrahlentherapie, Diakonie-Klinikum Schwa¨bisch Hall,
Diakoniestraße 10, D–74523 Schwa¨bisch Hall, Germany
bGymnasium bei St. Michael,
Tu¨ngentaler Str. 92, D–74523 Schwa¨bisch Hall, Germany
Abstract
The properties of a clinical LINAC are investigated for a study of photoactivation
cross sections slightly above the neutron threshold. As an example, the photoactiva-
tion of a tiny amount of gold by the 197Au(γ,n)196Au reaction has been measured.
The derived photon intensity is at least comparable to conventional and widely
used photon sources. In combination with its extremely stable operation, a clinical
LINAC ensures that photoactivation studies can be performed for a wide number
of targets with very limited beamtime.
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1 Introduction
The technique of photoactivation has found applications in various fields [1,2].
At low-energy accelerators photoactivation experiments are restricted to iso-
mers (see e.g. [3,4]); only few experiments have been carried out. The ma-
jority of photoactivation experiments is performed using bremsstrahlung with
endpoint energies of about 20 − 30MeV; in this case the huge cross section
of the (γ,n) reaction around the giant dipole resonance at energies of about
15MeV leads to excellent sensitivity of the photoactivation technique [2]. It
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has been shown that medical accelerators are able to provide a sufficient pho-
ton intensity for such experiments [5]. In the present investigation we focus on
photoactivation experiments at energies slightly above the neutron threshold
which are feasible at a clinical linear accelerator (cLINAC) with relatively low
photon energies up to 10MeV.
The experimental study of photon-induced cross sections has found increas-
ing interest in the last years. Most of the recent studies were motivated by
the astrophysical relevance of photon-induced reactions in the so-called as-
trophysical p-process or γ-process where neutron-deficient heavy nuclei are
synthesized by a series of (γ,n), (γ,α), and (γ,p) reactions at temperatures of
about two to three billions Kelvin (T9 = 2 − 3) [6,7,8,9,10,11]. At such high
temperatures the high-energy tail of the blackbody radiation spectrum has
a sufficient intensity to induce a noticeable reaction rate for photon-induced
reactions.
It has been shown that the astrophysically relevant energy window for (γ,n)
reactions is located slightly above the threshold of the (γ,n) reaction and
has a width of less than 1MeV [12]; the position of this window is almost
independent of the temperature T . In contrast the energy window for (γ,α)
reactions depends sensitively on the temperature T and has a much broader
width of several MeV. The position and width can be estimated from the
Gamow window of the inverse (α,γ) capture reaction. The position is shifted
by the Q-value of the (α,γ) reaction (Eeff(γ,α) = E
eff
(α,γ) + Qα), and the width is
practically identical as in the (α,γ) reaction [13].
Recent experiments have been performed with almost monochromatic photons
from laser Compton scattering (LCS) [11,14,15,16,17] as well as with contin-
uous photon energy distributions from bremsstrahlung [11,12,18,19,20,21]. In
addition, a new photon source using a superconducting wiggler at an electron
storage ring with the energy of several GeV has been suggested [22,13].
It is the aim of the present work to compare the performance of previously
used bremsstrahlung photon sources (e.g., S-DALINAC at TU Darmstadt or
ELBE at Forschungszentrum Dresden in Rossendorf or commercially available
electron accelerators) with the output of a cLINAC. In the present investiga-
tion we use the cLINAC of Diakoniekrankenhaus Schwa¨bisch Hall which is a
standard cLINAC manufactured by Elekta, Crawley, United Kingdom. The
measured yield from photoactivation of a gold sample via the 197Au(γ,n)196Au
reaction allows the determination of the number of photons in the clinically
used photon beam because the cross section of this reaction has been studied
carefully in a wide energy range [18,14,23]. We derive the number of photons
at an energy of 9MeV using a simplistic linear spectral distribution and a
realistic photon spectrum from a GEANT simulation.
2
The paper is organized as follows. In Sect. 2 the general properties of the
cLINAC are summarized. In Sect. 3 the experimental set-up for the pho-
toactivation of gold by the 197Au(γ,n)196Au reaction is presented. In Sect. 4
the experimental data are analyzed, and the photon density is derived from
the measured photoactivation yield. The experimental results are discussed in
Sect. 5 and compared to other photon sources in Sect. 6. Finally, conclusions
are given in Sect. 7.
2 Properties of a clinical LINAC
The cLINAC under study is an up-to-date cLINAC which has been installed in
2005 by the manufacturer Elekta. The following schematic view of the cLINAC
is summarized from the technical documentation of the cLINAC [24]. The
very stable and reliable operation of a cLINAC under clinical conditions is an
excellent basis for basic physics research. Typically a cLINAC is running every
working day. The required maintenance is 7 days per year of operation. The
manufacturer guarantees a 96% availability which corresponds to 10 further
days of unplanned maintenance per year. The overall availability of a cLINAC
is more than 90%. Such a high availability has indeed been achieved for the
cLINAC under investigation in its first two years of operation including all
its peripheral devices. The availability of the beam from the cLINAC is even
better.
The primary electron beam is generated in a gun with an energy of about
50 keV leading to an injection velocity of about 40% of the speed of light: v ≈
0.4 c. The electrons are accelerated in a copper cavity by 3GHz radiofrequency
(RF) with a peak power of about 5MW in the pulse and with a pulse repetition
frequency (PRF) of 200Hz or 400Hz (depending on the chosen energy). For
an electron energy of 10MeV a primary electron current of about 500mA in
the pulse can be roughly estimated assuming that 100% of the RF power are
converted into electron energy. Together with the PRF of 200Hz and a typical
pulse width of about 3µs this results in an average electron current of about
300µA.
Steering and focusing of the electron beam is achieved by standard magnetic
and electrostatic devices. An achromatic bending system is used to transport
the beam onto a massive tungsten target where the electron beam is stopped
and bremsstrahlung with an endpoint energy identical to the primary kinetic
electron energy is produced.
After a massive primary collimator with a thickness of about 10 cm the photon
beam hits a flattening filter. The bremsstrahlung emission process is focused
at forward angles. The shape of the flattening filter is optimized to obtain an
3
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Fig. 1. Schematic view of the photon beam production and collimation of a cLINAC.
Two target positions for photoactivation are shown: a close position at SSD ≈ 20 cm
which requires some modifiaction of the cLINAC and a second position at SSD
≈ 55 cm which can be used in the clinical set-up (see text).
almost flat photon angular distribution which finally has to deliver a flat dose
profile to the patient. The distance from the almost point-like photon source
to an irradiation position is called source-surface distance (SSD). A schematic
view of the bremsstrahlung production target and the collimation system is
given in Fig. 1.
Behind the flattening filter a thin segmented ionization chamber is mounted.
The various segments of the chamber are used to control the position and
flatness of the beam. In addition, because of the strong sensitivity of the
photon angular distribution on the electron energy, the ratio between outer
and inner segments of the ionization chamber is used to control the energy of
the primary electron beam.
Between ionization chamber and the diaphragm system a so-called wedge filter
may be used. This wedge leads to a well-defined asymmetric dose profile.
For the shaping of the photon beam according to the requirements of patient
treatment a system of diaphragms in X and Y direction allows to define
rectangular fields with a maximum size of 40×40 cm2 at the nominal distance
SSD = 100 cm. Additionally, a so-called multi-leaf collimator (MLC) allows to
define irregular field shapes according to the clinical requirements. Together
with the so-called wedge filter the diaphragm system requires about 35 cm
space below the ionization chamber.
The ionization chamber is an essential part of the cLINAC and its beam control
system. This restricts the positioning of the target samples for photoactivation
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experiments to distances larger than about 20 cm from the almost point-like
photon source. The diameter of the primary electron beam is typically less
than 2mm. For this closest position some parts of the cLINAC have to be
removed; otherwise such a close target position is not accessible. Without any
modification of the cLINAC, the closest target position is located at SSD
≈ 55 cm from the point-like photon source.
A typical cLINAC is able to provide electron beams at a number of fixed
energies. The cLINAC under study is configured to provide primary electrons
at E = 6MeV (X6) and 10MeV (X10). A variation of the pre-defined fixed
energies is possible by readjusting the operational parameters of the cLINAC.
Because of the fully digital operation of the cLINAC under investigation, the
pre-defined clinical beams can be restored within seconds by a software reload
of the original parameters.
The clinical energy definition of a photon beam is given by the so-called beam
quality factor which is derived from the measured depth dose curve in a water
phantom. The standard definition of the beam quality factor Q uses a set-
up with SSD = 100 cm from the practically point-like photon source to the
surface of the water phantom and a field size of 10×10 cm2. The beam quality
factor is then defined by the ratio of doses D20 and D10 measured at a depth
of 20 cm and 10 cm:
Q = D20/D10 (1)
Two typical depth-dose curves are shown in Fig. 2 for the available energies
X6 and X10; the corresponding beam quality factors are Q = 0.685 for X6
and Q = 0.732 for X10. It has been shown that the stability of cLINACs is
excellent. For the cLINAC under study we find very minor variations of Q of
less than 1% during typical irradiations with durations of a few minutes [25]
and a long-time stability within ±1%.
By readjustment of the X10 beam parameters we have increased and decreased
the electron energy. Two further depth dose profiles were measured where the
changes in electron energy translate to slightly increased and reduced beam
quality factors: Q> = 0.738 and Q< = 0.727. These changes in Q correspond
to a variation of the endpoint energy of about 500 keV. The depth dose profiles
with increased Q> and decreased Q< are shown in Fig. 2 by dash-dotted lines.
After restoring the original parameters of the X10 beam, a further depth
dose curve was measured. This second curve with the original X10 parameters
typically deviates by less than 0.1% from the first X10 depth dose curve, and
the beam quality factor of the second curve is Q = 0.732 which is identical to
the first measurement.
Under clinical conditions the cLINAC is able to provide a dose of slightly
5
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Fig. 2. Measured depth dose curves for two photon energies X6 (dashed line) and
X10 (full line) corresponding to beam quality factors Q = 0.685 and Q = 0.732.
The dash-dotted lines show depth dose profiles for X10 with slightly increased
Q> = 0.738 and reduced Q< = 0.727; these profiles have been measured using
the predefined X10 beam with slightly modified parameters. For comparison the
depth dependence for absorption-free radiation (proportional 1/r2) is also shown
(dotted line).
above 5Gy per minute in the dose maximum of the depth dose curve in a
water depth of about 1 − 2 cm. It is well-known that the average photon
energy of bremsstrahlung from a cLINAC is about or slightly less than one
third of the nominal endpoint energy [26]; i.e., for the X10 radiation in the
present experiment one finds an average photon energy of about E ≈ 3MeV.
A simple estimate of the photon intensity can be obtained as follows. From the
depth dose curve in Fig. 2 (which includes the obvious 1/r2 dependence) and
its comparison to the 1/r2 dependence it is possible to calculate that about
2.5% of the incoming photons are absorbed in a layer of 1 cm water. Thus, for
delivery of 1Gy in a 10× 10 cm2 layer with 1 cm thickness a deposited energy
of 0.1 J is required which corresponds to a primary energy of the photon beam
of 0.1 J/0.025 = 4 J. Together with the average photon energy of 3MeV =
4.8 × 10−13 J one finds that 8.3 × 1012 incoming photons are required for the
dose of 1Gy in this layer with a volume of V = 100 cm3. This corresponds to
8.3× 1010 photons per cm2 or a photon intensity of about 7× 109/(cm2 s) for
the delivery of 5Gy in one minute. The spectral intensity is of the order of
2×106/(keV cm2 s) assuming that the main intensity of a real bremsstrahlung
spectrum is located between 1 and 5MeV. The spectral intensity of more
than 106/(keV cm2 s) is more than one order of magnitude higher than 104 −
105/(keV cm2 s) as e.g. stated in [27] for the S-DALINAC.
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Fig. 3. Normalized energy distribution Φγ(E) for thick-target bremsstrahlung with
an endpoint energy E0 = 9.9MeV from a GEANT simulation (calculation taken
from [18]).
A typical energy distribution of bremsstrahlung is shown in Fig. 3. The energy
distribution has been calculated for an electron energy of E0 = 9.9MeV and a
thick copper target [18] using the simulation code GEANT [28]. A lower cutoff
of E = 1MeV was used in the simulation calculation to reduce the required
time for the computation. The absorption of photons in the electron target
and the flattening filter leads to a less sharp cutoff at similar energies in a
realistic cLINAC [26]. The shown energy distribution Φγ(E) is normalized to
unity:
E0∫
0
Φγ(E) dE = 1 (2)
The average energy
E =
E0∫
0
E Φγ(E) dE (3)
for the shown spectrum in Fig. 3 is close to 3MeV.
There is no perfect agreement between the calculated set-up in [18] and the
cLINAC of the present work. However, it has been shown in [29] that the spec-
tral shape of the energy distribution of bremsstrahlung depends only weakly
on the details of the set-up. A very similar shape to Fig. 3 was obtained from
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a simulation of a cLINAC in [26], and it has been shown that the calculated
spectral shape of bremsstrahlung of cLINACs is close to measured energy spec-
tra [26,30,31,32,33,34,35]. In particular, the spectral shape of a cLINAC close
to the endpoint energy has been analyzed in [36,37], and a parametrization is
given that corrects the simple Schiff formula for thin-target bremsstrahlung
[38] to the spectral shape of a cLINAC [36].
Furthermore, a small variation in the energy of the primary electron beam can
be taken into account in a simple way by a corresponding scaling the energy
axis in Fig. 3 [29]. Such a scaling has been applied in the data analysis in
Sect. 4.
3 Experimental Set-up
Two gold samples were irradiated for the present experiment. A thin foil with
a thickness of 3.7mg/cm2, a size of 40×40mm2, and a total weight of 59.2mg
was mounted at the target position without cLINAC modification at SSD
≈ 55 cm (see Fig. 1). A second target consisted of a larger amount (≈ 4 g) of
irregularly shaped 333-gold (33.3% mass fraction of gold, other constituents
are silver and copper in almost identical mass fractions). The second target
was mounted at a slightly larger distance. The absolute photon intensity was
determined from the activity of the thin gold foil whereas the decay spectrum
and the half-life of the decaying activity were measured using the larger target
with its higher count rates.
The irradiation time is software-restricted to a maximum of about 300Gy cor-
responding to an irradiation time of about 55 minutes. This maximum irradi-
ation time was used to activate the two gold targets by the 197Au(γ,n)196Au
reaction using the X10 photon beam. It is possible to extend the irradiation
to longer times by a manual restart of the beam. However, as can be seen
in the following, one hour irradiation time turned out to be sufficient for a
measurable activation yield.
After irradiation the activity of the target samples was measured with a well-
shielded standard NaI(Tl) detector. The γ-ray spectrum is shown in Fig. 4. Al-
though the energy resolution of the NaI detector is not sufficient to resolve the
two main decay lines at Eγ = 356 keV and 333 keV, the signal-to-background
ratio is very good because the integrated background in the shown energy
range of the spectrum is below one count per second. The properties of the
NaI detector are sufficient for the determination of the photon intensity in the
present experiment. It is obvious that the NaI detector has to be replaced by a
high-resolution detector for detailed photoactivation studies, particularly for
target nuclei with low abundances or produced nuclei with long half-lives or
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Fig. 4. γ-ray spectrum of the decay of 196Au, measured with a NaI detector. The
energy resolution of the NaI detector is not sufficient to resolve the two main lines
at 333 keV and 356 keV. Slightly above 400 keV a further peak can be seen which
is composed of sum lines of X-rays and 333 keV or 356 keV, the weak decay line at
426 keV, and a decay line of 198Au which was produced by neutron capture in the
197Au(n,γ)198Au reaction. Additionally, the calibration spectrum from 131I is shown
with a dotted line.
weak γ-decay branches.
The absolute calibration for the NaI detector was performed with a calibrated
source of 131I. The main γ-line from the decay of 131I at E = 364 keV almost
coincides with the γ-ray energies from the decay of 196Au at E = 356 keV
(branching per decay 87.0 ± 0.8%) and 333 keV (22.8 ± 0.6%); note that
the sum of the branchings exceeds 100% because of cascade transitions. For
simplicity, a broad integration range of the spectrum from about 250 keV and
500 keV has been used in the data analysis. This window covers the main decay
lines of 196Au and 131I. As pointed out above, the background in this broad
energy window is below one count per second which has to be compared to
the count rate of above 100 counts per second for the larger gold sample and
more than 10 000 counts per second for the 131I calibration source where the
deadtime of the NaI detector and its electronics is still below 5%.
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Fig. 5. Decay curve of the activity of 196Au measured over more than three half-lives.
The inset compares our new result to the adopted value from the ENSDF data base
[39,40] and the recently measured precise result of [41].
4 Data analysis
In a first part of the data analysis the activity of the gold sample has been
measured for more than three half-lives. The result is shown in Fig. 5. The ob-
tained half-life of 196Au is T1/2 = 147.75± 0.13 h which is in rough agreement
with the adopted value of 148.39± 0.24 h [39,40] and overlaps within 2 σ with
the recently measured precise number of 148.006± 0.015 h [41]. It is interest-
ing to note that a small component (< 5%) with a shorter half-life around 3
days is required for an excellent fit (χ2red ≈ 1) of the decay curve; this compo-
nent comes probably from the decay of 198Au which can be produced by the
197Au(n,γ)198Au reaction. A very weak decay line of 198Au was also observed
in the γ-ray spectrum of [18]. The neutrons may have been produced in the
target sample itself by the 197Au(γ,n)196Au reaction and/or in the tungsten
diaphragms of the cLINAC by the 183,186W(γ,n)182,185W reactions.
The calculation of the photon intensity was performed as follows. The activity
of the thin gold foil was measured after the irradiation to be 3.71 counts per
second. The measured activity was converted to the number of produced 196Au
nuclei taking into account the decay constant of 196Au, the γ-ray branching
in the decay of 196Au and 131I which was used for the detector calibration,
and the detector efficiency. The total number of 197Au(γ,n)196Au reactions
and produced 196Au nuclei was (2.38 ± 0.25) × 107 where the uncertainty is
dominated by the absolute calibration of the NaI detector.
10
The cross section of the 197Au(γ,n)196Au reaction is well-known from the
threshold at 8.071MeV up to the giant dipole resonance. We use the parametri-
zation of [18] which is based on the bremsstrahlung and photoactivation ex-
periment of [18], one recent data point using LCS photons and direct neutron
detection [14], and positron-in-flight annihilation experiment by [23]. The un-
certainty of the 197Au(γ,n)196Au reaction cross section is smaller than 5% over
the whole energy range of the present experiment.
The cross section, photon intensity, and number of reactions are related by
the yield integral
NR = k NT ×
E0∫
Sn
σ(E) Φγ(E,E0) dE (4)
with the number of reactions NR, number of target atoms in the sample NT ,
normalized bremsstrahlung spectrum Φγ(E,E0) at endpoint energy E0, cross
section σ(E), and a scaling factor k for the normalized bremsstrahlung spec-
trum. The integral in Eq. (4) is limited by the neutron separation energy Sn
and the endpoint energy E0. The number of photons nγ(E,E0) (per keV and
cm−2) for this irradiation is finally obtained by
nγ(E,E0) = k × Φγ(E,E0) (5)
The scaling factor k has been adjusted to reproduce the experimental yield.
The result is shown in Fig. 6 for the distribution Φγ(E,E0 = 10MeV) at SSD
≈ 55 cm (see also Fig. 3). The beam quality factor of Q = 0.732 which was
measured in the depth dose curve (see Fig. 2) indicates that the endpoint
energy must be close to E0 = 10MeV.
For experiments slightly above the (γ,n) threshold the results depend sen-
sitively on the endpoint energy E0 in the experiment. Therefore, the above
procedure for the determination of the scaling factor k and the number of
photons nγ(E,E0) has been repeated using four normalized bremsstrahlung
spectra Φ(E,E0) with different endpoint energies E0 = 9, 10, 11, and 12MeV
which were obtained from the basic Φγ(E,E0 = 9.9MeV) at the endpoint
energy E0 = 9.9MeV by a simple scaling of the energy axis (see Fig. 3).
The results are also shown in Fig. 6 (dotted lines). It is obvious that a lower
(higher) number of photons at higher (lower) endpoint energies E0 is required
to fit the experimental photoactivation yield.
As a further check we used also a simplistic linear spectral shape between the
energies of 8 and 10MeV. The derived photon intensity from this simplistic
spectral shape agrees at energies around 9MeV within less than 10% with the
11
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Fig. 6. Number of photons nγ(E,E0) at SSD ≈ 55 cm determined from the pho-
toactivation yield in the 197Au(γ,n)196Au reaction. The thick lines show the cross
section of the 197Au(γ,n)196Au reaction in the parametrization of [18] (right scale)
and the photon intensity nγ(E,E0) for an endpoint energy of E0 = 10MeV (left
scale). Additionally, the dashed lines show the results for lower (E0 = 9MeV) and
higher (E0 = 11 and 12MeV) endpoint energies for comparison. The hatched line
represents a simplistic linear spectral shape between 8 and 10MeV.
result using the spectral shape from the GEANT simulation with endpoint
energy E0 = 10MeV.
Using the realistic bremsstrahlung spectrum at E0 = 10MeV, we find a num-
ber of photons of about nγ ≈ 2× 10
9/(keV cm2) at energies around 9MeV for
SSD ≈ 55 cm. These photons were irradiated within less than one hour. This
corresponds to a photon intensity of about 6× 105/(keV cm2 s) at E = 9MeV
and SSD ≈ 55 cm. Because of the spectral shape of the bremsstrahlung spec-
trum, the number of photons at lower energies is much higher. E.g., around
E = 3MeV we find nγ ≈ 3 × 10
10/(keV cm2) at SSD ≈ 55 cm which corre-
sponds to an intensity of slightly below 107/(keV cm2 s) at this SSD.
In Sect. 2 a rough estimate of the photon intensity of 2 × 106/(keV cm2 s)
around 3MeV was given for the distance of 100 cm between point-like photon
source and water phantom (SSD = 100 cm). Consequently, for the smaller SSD
of ≈ 55 cm of the photoactivation experiment one expects about a factor of
four higher photon intensity, i.e. 8×106/(keV cm2 s). This rough estimate from
the dose absorption in a water tank is in excellent agreement with the number
of slighly below 107/(keV cm2 s) which was derived in the previous paragraph
using the bremsstrahlung spectrum with E0 = 10MeV. If one uses instead the
bremsstrahlung spectrum at E0 = 9MeV (11MeV), one finds a photon inten-
sity which is a factor of about five higher (three lower). This finding demon-
strates the sensitivity of photoactivation yields at endpoint energies slightly
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above the (γ,n) reaction threshold and confirms that the bremsstrahlung spec-
trum of the cLINAC has an endpoint energy close to E0 = 10MeV.
Further study of the bremsstrahlung spectrum of the cLINAC is required to
reduce the uncertainties of the above data analysis which are of the order about
25% for the derived number of photons. For future experiments it might be
helpful to establish a standard for the normalization of experiments which
consists of several nuclei with different thresholds for the (γ,n) reaction. This
can be done by measurements with quasi-monochromatic photons. At present
precise data down to the threshold of the (γ,n) reaction are available e.g. for
197Au with Sn = 8071 keV [18,14],
187Re with Sn = 7363 keV [15,20,42], and
186W with Sn = 7194 keV [43,15,19].
5 Discussion
The number of photons nγ(E,E0) – as shown in Fig. 6 for the SSD ≈ 55 cm –
is sufficient to obtain a reasonable yield in (γ,n) experiments with measuring
times of the order of one hour. Such experiments can be done easily at a
cLINAC without major efforts for preparing the experiment. Reducing the
SSD by almost a factor of three from 55 cm to about 20 cm at the close target
position (see Fig. 1) leads to an increased photon intensity by almost one order
of magnitude compared to the SSD of this experiment. However, this reduction
of the SSD requires some preparation time and mechanical modifications which
cannot be done easily at a cLINAC in daily clinical use.
A variation of the electron beam energy requires modification and optimiza-
tion of the beam parameters which can be controlled by simultaneous mea-
surements of depth dose profiles. Note that the beam quality factor of the
depth dose profile is an excellent measure for the electron beam energy (see
also Fig. 2). Although such modifications of the electron beam are possible
in principle, the required effort and patient safety considerations will hamper
larger series of photonuclear experiments at any cLINAC in routine clinical
use because it must be absolutely sure that any modification of beam parame-
ters for an experiment is removed before clinical use of the cLINAC. However,
because the required beam time for photonuclear experiments is quite small,
it seems nevertheless possible to perform larger series of photonuclear exper-
iments e.g. during the set-up of a new cLINAC at the test facility of the
manufacturer or at a newly installed cLINAC before clinical use.
Finally, radiation safety issues have to be considered before any larger experi-
mental programs. Typically, the radiation protection of a cLINAC is calculated
for a total dose of 1000Gy per week (delivered at SSD = 100 cm) which is by
far sufficient to treat about 50 patients per day with doses of 2Gy. In clinical
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use, most of the time is required for patient positioning, and the real irradia-
tion time is quite short (typically far less than one minute per patient). The
single irradiation of this experiment took about one hour and required a total
dose of about 300Gy. Such an irradiation corresponds to about one third of
maximum dose per week, and obviously it cannot be performed several times
a week.
However, the radiation safety problem may be solved or at least dramatically
reduced. In clinical operation, the cLINAC is rotated around the patient. Radi-
ation protection is designed so that 1000Gy per week can safely be irradiated
in any direction. Often one can find directions with much lower radiation expo-
sure to the surrounding area. E.g., for the cLINAC under study the radiation
exposure to the operators varies by about a factor 5 depending on the irra-
diation angle. It might be discussed with the regulatory authority to extend
the radiation time by this factor of 5 at a well-defined radiation direction with
low exposure to the operators. Additionally, the access to areas with high
exposures may be prohibited or restricted in time.
6 Comparison to other electron accelerators and photon sources
The photon intensity which can be obtained without any modifications at SSD
≈ 55 cm is about one order of magnitude higher than the available intensity at
the regular irradiation position at the S-DALINAC accelerator in Darmstadt
[27]. Here simultaneous photon scattering [44] can be measured to reduce
the uncertainties of the spectral shape of the photon spectrum. At a second
irradiation position close to the photon source at S-DALINAC one finds a
photon intensity which is a factor of 300 higher than at the standard irradiation
position. This higher intensity is comparable to the increased intensity at a
smaller SSD of the cLINAC of the present investigation.
The ELBE accelerator of Forschungszentrum Dresden is able to provide huge
electron beam currents. However, at the standard irradiation position for nu-
clear resonance fluorescence experiments a thin radiator target is used lead-
ing to photon intensities of the order of 5 × 104/(keV s) at E = 7MeV for
bremsstrahlung with E0 = 10MeV [45]. A much higher photon intensity can
be obtained at the beam dump of the high-current electron beam. A photon
flux of “up to 1010 cm−2 s−1MeV−1” is stated in [46] but the corresponding
photon energy is not given in [46]. The determination of the energy spectrum
of the bremsstrahlung and the absolute normalization of the bremsstrahlung
are more complicated compared to the standard irradiation position. Nev-
ertheless, a few remarkable experiments have been performed at ELBE. In
particular, first experimental data for (γ,α) reactions have been obtained [21].
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There are a number of commercially available electron accelerators which may
be equipped with a massive target for bremsstrahlung production. Electro-
static accelerators like dynamitrons and van-de-Graaf or pelletron accelerators
provide high electron currents; however, the available energy is often limited.
In particular, this is the case for single-ended electron accelerators. E.g. the
S-Series pelletron from National Electrostatics Corporation (NEC) (“S” for
single-ended) is limited to electron energies below 5MeV [47]. The same limit
of 5MeV holds for the Radiation Dynamics (RDI) dynamitron [48]. Because of
the limited electron energy photoactivation is practically restricted to isomers
[3,4].
A high-power, high-energy electron accelerator, the so-called rhodotron accel-
erator (TT series), is available from Ion Beam Applications (IBA) [49] with
energies of 10MeV and beam power up to almost 200 kW. However, the only
commercially available rhodotron with variable energy is limited to 7.5MeV
which is again too low for photoactivation experiments. Some development
is needed for the 10MeV rhodotron as an excellent energy-variable photon
source. An energy-variable electron beam has to be implemented which is a
complicated task, in particular for continuously varying electron energies.
Any comparison with quasi-monochromatic photon sources as e.g. AIST [50]
at Tsukuba or HIγS [51] at Duke University, Durham, is difficult because
the spectral intensity of quasi-monochromatic photon soures is very high (or
infinity for an ideal monochromatic photon source). However, the absolute
number of photons is typically lower compared to bremsstrahlung facilities.
It depends on the requirements of the respective experiment whether a quasi-
monochromatic photon source or a bremsstrahlung photon source is to be
preferred.
Recently, a new high-intensity non-monochromatic photon source was sug-
gested using synchrotron radiation from a 10T superconducting wiggler at a
many-GeV electron storage ring at SPring-8 [22]. A first proposal has been
accepted, and hopefully this first part of the MeV photon source will become
operational within the next years. The properties of this outstanding pho-
ton source cannot be reached by a cLINAC but it can be expected that the
beamtime at such a huge facility will be very limited.
7 Conclusions
A photon intensity of about 6×105/(keV cm2 s) at E = 9MeV can be achieved
at the cLINAC under investigation without any modification to the clinical set-
up. The photon intensity may be increased by almost one order of magnitude
by minor modifications. This intensity is at least comparable to photon sources
15
which have been used in recent photonuclear experiments.
Furthermore, the excellent stability and reproducibility of the beam of a
cLINAC are good prerequisites for such experiments. The required beam times
are short and can be done during the night when most cLINACs are not in
operation.
In summary, a cLINAC is an excellent photon source for photonuclear ex-
periments. Besides the radiation safety problem, there is not any physical
argument that stands against photonuclear research at a cLINAC.
Acknowledgments
We thank Th. Aller for his assistance and patience during the measurements
of the γ-ray spectra, the group Physik in der Medizin from Gymnasium St.
Michael (M. Amend, A. Angerer, J. Bahmu¨ller, J. Fo¨rstel, B. Franz, N. Pohl,
J. Scheu, A. Sebek, L. Zipperer) for their help in the experiment, and Th.
Preisendanz for the support of this project.
References
[1] Proc. 11th International Conference on Modern Trends in Activation Analysis
(MTAA-11), Surrey, Guildford, J. Radioanal. Nucl. Chem. 271 (2007).
[2] K. Masumoto and Ch. Segebade, in Encyclopedia of Analytical Chemistry, ed.
R. A. Meyers, Wiley Interscience (2000), doi 10.1002/9780470027318.a6211.
[3] K. X. Nghiem and L. Lakosi, J. Radioanal. Nucl. Chem. 230, 143 (1998).
[4] D. Belic et al., Nucl. Inst. Meth. Phys. Res. A 463, 26 (2001).
[5] T. Webb, W. Beezhold, L. DeVeaux, F. Harmon, J. Petrisko, R. Spaulding, R.
Assink, Proc. Particle Accelerator Conference PAC 2005, p. 2363 (2005).
[6] S. E. Woosley and W. M. Howard, Astroph. J. Suppl. 36, 285 (1978).
[7] D. L. Lambert, Astron. Astrophys. Rev. 3, 201 (1992).
[8] T. Rauscher, A. Heger, R. D. Hoffman, and S. E. Woosley, Astroph. J. 576, 323
(2002).
[9] M. Arnould and S. Goriely, Phys. Rep. 384, 1 (2003).
[10] T. Hayakawa, N. Iwamoto, T. Shizuma, T. Kajino, H. Umeda, and K. Nomoto,
Phys. Rev. Lett. 93, 161102 (2004).
16
[11] H. Utsunomiya, P. Mohr, A. Zilges, M. Rayet, Nucl. Phys. A777, 459 (2006).
[12] P. Mohr, K. Vogt, M. Babilon, J. Enders, T. Hartmann, C. Hutter, T. Rauscher,
S. Volz, A. Zilges, Phys. Lett. B 488, 127 (2000).
[13] P. Mohr, Zs. Fu¨lo¨p, H. Utsunomiya, Europ. Phys. J. A 32, 357 (2007).
[14] H. Utsunomiya, H. Akimune, S. Goko, M. Ohta, H. Ueda, T. Yamagata, K.
Yamasaki, H. Ohgaki, H. Toyokawa, Y.-W. Lui, T. Hayakawa, T. Shizuma, E.
Khan, and S. Goriely, Phys. Rev. C 67, 015807 (2003).
[15] T. Shizuma, H. Utsunomiya, P. Mohr, T. Hayakawa, S. Goko, A. Makinaga,
H. Akimune, T. Yamagata, M. Ohta, H. Ohgaki, Y.-W. Lui, H. Toyokawa, A.
Uritani, and S. Goriely, Phys. Rev. C 72, 025808 (2005).
[16] S. Goko, H. Utsunomiya, S. Goriely, A. Makinaga, T. Kaihori, S. Hohara, H.
Akimune, T. Yamagata, Y.-W. Lui, H. Toyokawa, A. J. Koning, and S. Hilaire,
Phys. Rev. Lett. 96, 192501 (2006).
[17] H. Utsunomiya, A. Makinaga, S. Goko, T. Kaihori, H. Akimune, T. Yamagata,
M. Ohta, H. Toyokawa, S. Mu¨ller, Y.-W. Lui, and S. Goriely, Phys. Rev. C 74,
025806 (2006).
[18] K. Vogt, P. Mohr, M. Babilon, W. Bayer, T. Hartmann, C. Hutter, T. Rauscher,
K. Sonnabend, S. Volz, A. Zilges, Nucl. Phys. A707, 241 (2002).
[19] K. Sonnabend, K. Vogt, D. Galaviz, S. Mu¨ller, and A. Zilges, Phys. Rev. C 70,
035802 (2004).
[20] S. Mu¨ller, A. Kretschmer, K. Sonnabend, A. Zilges, D. Galaviz, Phys. Rev. C
73, 025804 (2006).
[21] A. Wagner, R. Beyer, M. Erhard, F. Do¨nau, E. Grosse, A. Hartmann, A.R.
Junghans, L. Ka¨ubler, K. Kosev, S. Mallion, C. Nair, N. Nankov, G. Rusev, K.D.
Schilling, W. Schulze and R. Schwengner, J. Phys. G 31, S1969 (2005).
[22] H. Utsunomiya, S. Goko, K. Soutome, N. Kumagai, and H. Yonehara, Nucl.
Inst. Meth. Phys. Res. A 538, 225 (2005).
[23] B. L. Berman, R. E. Pywell, S. S. Dietrich, M. N. Thompson, K. G. McNeill,
J. W. Jury, Phys. Rev. C 36, 1286 (1987).
[24] Elekta Digital Accelerator, Technical Training Guide, 2003 (unpublished).
[25] P. Mohr, S. Brieger, J. Stahl, G. Witucki, Strahlenth. Onkol. 183, 327 (2007).
[26] F. Verhaegen and J. Seuntjens, Phys. Med. Biol. 48, R107 (2003).
[27] P. Mohr, J. Enders, T. Hartmann, H. Kaiser, D. Schiesser, S. Schmitt, S. Volz,
F. Wissel, A. Zilges, Nucl. Inst. Meth. Phys. Res. A 423, 480 (1999).
[28] Software package GEANT Detector description and simulation tool,
http://wwwinfo.cern.ch/asd/geant/.
17
[29] K. Vogt, P. Mohr, M. Babilon, J. Enders, T. Hartmann, C. Hutter, T. Rauscher,
S. Volz, and A. Zilges, Phys. Rev. C 63, 055802 (2001).
[30] R. Mohan, C. Chui, and L. Lidofski, Med. Phys. 12, 592 (1985).
[31] A. B. Faddegon, C. K. Ross, D. W. O. Rogers, Med. Phys. 17, 773 (1990).
[32] A. B. Faddegon, C. K. Ross, D. W. O. Rogers, Med. Phys. 18, 727 (1991).
[33] A. B. Faddegon and D. W. O. Rogers, Nucl. Inst. Meth. Phys. Res. A 327, 556
(1993).
[34] D. Sheikh-Bagheri and D. W. O. Rogers, Med. Phys. 29, 379 (2002).
[35] D. Sheikh-Bagheri and D. W. O. Rogers, Med. Phys. 29, 391 (2002).
[36] M. Krmar, D. Nikolic, P. Krstonosic, S. Cora, P. Francescon, P. Chiovati, A.
Rudic, Med. Phys. 29, 932 (2002).
[37] M. Krmar, K. Ganezer, G. Pantelic, P. Krstonosic, Nucl. Inst. Meth. Phys. Res.
A 532, 533 (2004).
[38] L. I. Schiff, Phys. Rev. 83, 252 (1951).
[39] Web data base ENSDF http://www.nndc.bnl.gov/ensdf/, Brookhaven National
Laboratory, Version April 5th, 2007.
[40] H. Ikegami, K. Sugiyama, T. Yamazaki, M. Sakai, Nucl. Phys. 41, 130 (1963).
[41] K. Lindenberg, F. Neumann, D. Galaviz, T. Hartmann, P. Mohr, K. Vogt,
S. Volz, A. Zilges, Phys. Rev. C 63, 047307 (2001).
[42] P. Mohr, S. Goriely, T. Shiyuma, T. Hazakawa, PoS(NIC-IX) 142 (2007).
[43] P. Mohr, T. Shizuma, H. Ueda, S. Goko, A. Makinaga, K. Y. Hara, T. Hayakawa,
Y.-W. Lui, H. Ohgaki, and H. Utsunomiya, Phys. Rev. C 69, 032801(R) (2004).
[44] U. Kneissl, H. H. Pitz, and A. Zilges, Prog. Part. Nucl. Phys. 37, 349 (1996).
[45] A. Wagner, http://www.fzd.de/ELBE (2006).
[46] M. Erhard, A. R. Junghans, R. Beyer, E. Grosse, J. Klug, K. Kosev, C. Nair,
N. Nankov, G. Rusev, K. D. Schilling, R. Schwengner, and A. Wagner, Europ.
Phys. J. A 27, s01, 135 (2006).
[47] http://www.pelletron.com/sseries.htm.
[48] http://www.iba-worldwide.com/rdi/.
[49] http://www.iba-worldwide.com/industrial/product-range/rhodotron/index.php.
[50] H. Ohgaki, S. Sugiyama, T. Yamazaki, T. Mikado, M. Chiwaki, K. Yamada, R.
Suzuki, T. Noguchi, T. Tomimasu, IEEE Trans. Nucl. Sci. 38, 386 (1991).
[51] H. R. Weller and M. W. Ahmed, Mod. Phys. Lett. A 18, 1569 (2003).
18
